Detailed transabdominal fetal anatomic scanning in the late first trimester versus the early second trimester of pregnancy

Journal of Ultrasound in Medicine

Volumn 34, Issue 1, 2015, Pages 143-149

  Yagel, Simcha ^a   Cohen, Sarah M ^a   Porat, Shay ^a   Daum, Hagit ^a   Lipschuetz, Michal ^a   Amsalem, Hagai ^a   Messing, Baruch ^b   Valsky, Dan V ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b Mayanei Hayeshua Medical Center   (Israel)

Author keywords

Fetal anatomic screening; First trimester screening; Noninvasive prenatal testing; Obstetric ultrasound; Targeted organ scanning

Indexed keywords

DIAGNOSIS; DIGESTIVE SYSTEM; ECHOCARDIOGRAPHY; MAPPING; VISUALIZATION;

CENTRAL NERVOUS SYSTEMS; FETAL ECHOCARDIOGRAPHY; FIRST TRIMESTERS; GESTATIONAL AGE; LONGITUDINAL STUDY; POLYCYSTIC KIDNEY DISEASE; PRENATAL TESTING; VENTRICULAR SEPTAL DEFECT;

SCANNING;

ADULT; COMPARATIVE STUDY; CONGENITAL DISORDER; ECHOGRAPHY; FEMALE; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; LONGITUDINAL STUDY; MIDDLE AGED; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PROSPECTIVE STUDY; SECOND TRIMESTER PREGNANCY; YOUNG ADULT;

ADULT; CONGENITAL ABNORMALITIES; FEMALE; GESTATIONAL AGE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PROSPECTIVE STUDIES; ULTRASONOGRAPHY, PRENATAL; YOUNG ADULT;

EID: 84920411644     PISSN: 02784297     EISSN: 15509613     Source Type: Journal    
DOI: 10.7863/ultra.34.1.143     Document Type: Article

References (35)

1. Yagel S. Non-invasive prenatal testing: more questions than answers. Ultrasound Obstet Gynecol 2013; 42:369-372.
2. Nicolaides KH. A model for a new pyramid of prenatal care based on the 11 to 13 weeks' assessment. Prenat Diagn 2011; 31:3-6.
3. Smrcek JM, Berg C, Geipel A, Fimmers R, Diedrich K, Gembruch U. Early fetal echocardiography: heart biometry and visualization of cardiac structures between 10 and 15 weeks' gestation. J Ultrasound Med 2006; 25:173-182.
4. Yagel S, Weissman A, Rotstein Z, et al. Congenital heart defects: natural course and in utero development. Circulation 1997; 96:550-555.
5. Allan LD. Evolution of echocardiographic findings in the fetus. Circulation 1997; 96:391-392.
6. Allan LD, Crawford DC, Tynan M. Evolution of coarctation of the aorta in intrauterine life. Br Heart J 1984; 52:471-473.
7. Syngelaki A, Chelemen T, Dagklis T, Allan LD, Nicolaides KH. Challenges in the diagnosis of fetal non-chromosomal abnormalities at 11- 13 weeks. Prenat Diagn 2011; 31:90-102.
8. Grande M, Arigita M, Borobio V, Jimenez JM, Fernandez S, Borrell A. First-trimester detection of structural abnormalities and the role of aneuploidy markers. Ultrasound Obstet Gynecol 2012; 39:157-163.
9. Borrell A, Robinson JN, Santolaya-Forgas J. Clinical value of the 11- To 13 + 6-week sonogram for detection of congenital malformations: A review. Am J Perinatol 2011; 28:117-124.
10. Benn P, Cuckle H, Pergament E. Non-invasive prenatal testing for aneuploidy: current status and future prospects. Ultrasound Obstet Gynecol 2013; 42:15-33.
11. Cuckle H, Benn P, Pergament E. Clinical utility and cost of non-invasive prenatal testing. J Matern Fetal Neonatal Med 2014; 27:320-321.
12. Bianchi DW, Parker RL, Wentworth J, et al. DNA sequencing versus standard prenatal aneuploidy screening. N Engl J Med 2014; 370:799-808.
13. Dolk H, Loane M, Garne E. The prevalence of congenital anomalies in Europe. Adv Exp Med Biol 2010; 686:349-364.
14. Dolk H, Loane M, Garne E. Congenital heart defects in Europe: Prevalence and perinatal mortality, 2000 to 2005. Circulation 2011; 123:841- 849.
15. International Society of Ultrasound in Obstetrics and Gynecology; Carvalho JS, Allan LD, Chaoui R, et al. ISUOG practice guidelines (updated): Sonographic screening examination of the fetal heart. Ultrasound Obstet Gynecol 2013; 41:348-359.
16. Yagel S, Cohen SM, Achiron R. Examination of the fetal heart by five short-axis views: A proposed screening method for comprehensive cardiac evaluation. Ultrasound Obstet Gynecol 2001; 17:367-369.
17. Yagel S, Arbel R, Anteby EY, Raveh D, Achiron R. The three vessels and trachea view (3VT) in fetal cardiac scanning. Ultrasound Obstet Gynecol 2002; 20:340-345.
18. Chiu RW, Akolekar R, Zheng YW, et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ 2011; 342: c7401.
19. Chiu RW, Chan KC, Gao Y, et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci USA 2008; 105:20458- 20463.
20. Chiu RW, Sun H, Akolekar R, et al. Maternal plasma DNA analysis with massively parallel sequencing by ligation for noninvasive prenatal diagnosis of trisomy 21. Clin Chem 2010; 56:459-463.
21. Costa JM, Benachi A, Gautier E. New strategy for prenatal diagnosis of X-linked disorders. N Engl J Med 2002; 346:1502.
22. Fan HC, Blumenfeld YJ, Chitkara U, Hudgins L, Quake SR. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci USA 2008; 105:16266-16271.
23. Liao GJ, Lun FM, Zheng YW, et al. Targeted massively parallel sequencing of maternal plasma DNA permits efficient and unbiased detection of fetal alleles. Clin Chem 2011; 57:92-101.
24. Gardiner HM. First-trimester fetal echocardiography: routine practice or research tool? Ultrasound Obstet Gynecol 2013; 42:611-612.
25. Rossi AC, Prefumo F. Accuracy of ultrasonography at 11-14 weeks of gestation for detection of fetal structural anomalies: A systematic review. Obstet Gynecol 2013; 122:1160-1167.
26. Iliescu D, Tudorache S, Comanescu A, et al. Improved detection rate of structural abnormalities in the first trimester using an extended examination protocol. Ultrasound Obstet Gynecol 2013; 42:300-309.
27. Sotiriadis A, Papatheodorou S, Eleftheriades M, Makrydimas G. Nuchal translucency and major congenital heart defects in fetuses with normal karyotype: A meta-analysis. Ultrasound Obstet Gynecol 2013; 42:383-389.
28. Parry S, Simhan H, Elovitz M, Iams J. Universal maternal cervical length screening during the second trimester: Pros and cons of a strategy to identify women at risk of spontaneous preterm delivery. Am J Obstet Gynecol 2012; 207:101-106.
29. Nanda S, Savvidou M, Syngelaki A, Akolekar R, Nicolaides KH. Prediction of gestational diabetes mellitus by maternal factors and biomarkers at 11 to 13 weeks. Prenat Diagn 2011; 31:135-141.
30. Plasencia W, Garcia R, Pereira S, Akolekar R, Nicolaides KH. Criteria for screening and diagnosis of gestational diabetes mellitus in the first trimester of pregnancy. Fetal Diagn Ther 2011; 30:108-115.
31. Berghella V. Universal cervical length screening for prediction and prevention of preterm birth. Obstet Gynecol Surv 2012; 67:653-658.
32. Greco E, Lange A, Ushakov F, Calvo JR, Nicolaides KH. Prediction of spontaneous preterm delivery from endocervical length at 11 to 13 weeks. Prenat Diagn 2011; 31:84-89.
33. Bujold E, Roberge S, Lacasse Y, et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: A meta-analysis. Obstet Gynecol 2010; 116:402-414.
34. Roberge S, Nicolaides KH, Demers S, Villa P, Bujold E. Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: A metaanalysis. Ultrasound Obstet Gynecol 2013; 41:491-499.
35. Achiron R, Rotstein Z, Lipitz S, Mashiach S, Hegesh J. First-trimester diagnosis of fetal congenital heart disease by transvaginal ultrasonography. Obstet Gynecol 1994; 84:69-72.